AI-enabled patient companion platform for pharmaceutical companies supporting disease management, therapy, and clinical research; focuses on regulated digital health (SaMD, Digital Therapeutics, connected health).
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €21.5 M | Feb, 2026 | unspecified |
Industries
Frequently Asked Questions
Where is Dawn Health located?
Dawn Health is located in Kopenhagen, Denmark.
What industries does Dawn Health operate in?
Dawn Health operates in the following industries: digital health, healthcare, pharmaceuticals, clinical trials, software-as-a-medical-device, digital therapeutics.
How much total funding has Dawn Health raised?
Dawn Health has raised a total of $21,500,000.
Who are the investors in Dawn Health?
The investors in Dawn Health are: Cipio Partners, Chr. Augustinus Fabrikker (CAF).
What is Dawn Health?
Dawn Health is a digital health platform that offers evidence-based treatment for insomnia, primarily using Cognitive Behavioral Therapy for Insomnia to help individuals improve their sleep quality and duration.
How does the Dawn Health program help users?
The program helps users by providing a personalized sleep coach and a structured mobile app experience that focuses on changing the behaviors and thought patterns that contribute to chronic sleep issues.
What methodology does Dawn Health use for sleep therapy?
The platform utilizes Cognitive Behavioral Therapy for Insomnia, which is considered the gold standard for treating chronic sleep problems without the need for long-term medication.
Does Dawn Health provide human coaching?
Yes, users are matched with a dedicated sleep coach who provides guidance, accountability, and support throughout the duration of the program to ensure the best possible outcomes.
Can Dawn Health help with reducing sleep medication use?
Many users find that by implementing the behavioral changes taught in the program, they can naturally improve their sleep and work with their healthcare providers to decrease their reliance on pharmacological sleep aids.